Bayer opens first SeedGrowth Centre in Africa
The SeedGrowth Centre has the potential to help farmers in the region to not only secure, but significantly increase their yields in key crop.
Johannesburg, August 25, 2016 – Bayer South Africa has opened its first multi-million rand SeedGrowth Centre, the first of its kind for the company in Africa, at its Production Facility in Nigel outside Johannesburg. The opening of the centre is a reconfirmation of Bayer’s commitment to the agricultural sector in the region and is one of only 16 other such centres in the world.
Bayer’s SeedGrowth Centre is set to provide a series of advantages for every player in the seed treatment value chain, including high-quality coatings, innovative products and powerful application equipment all linked to services and advice taylormade to specific customer needs. The result: higher productivity, profitability and sustainability of farming. In addition, onging research will allow Bayer to provide customized solutions to seed companies as well as provide crop benefits such as improved plantability and pest/disease management to farmers.
Speaking at the opening, Dr Klaus Eckstein, CEO and Head of the Crop Science Division for Bayer in Southern Africa said, “We have the opportunity to provide the latest in research at a local level to support our farmers to compete globally. We believe that through Seed Treatment we now have the tool to truly add value to the developing farmer through an innovation such as seed treatment which can comfortably increase yields by 30 % per hectare and more, specifically in the Southern African region. At Bayer, we believe that growing Seed Treatment in Africa is critical in order to support farmers to be commercially viable.”
The centre will be supporting the industry further by:
- Training seed company production staff in the principals of stewardship
- Supporting Seed Companies in upscaling processes in a pilot plant environment
- Acting as a base for research in terms of optimising seed treatment technology
- Demonstrating how Bayer’s equipment works and what equipment will fit customer facilities
“The whole is more than the sum of its individual parts. That's the secret of the added value that Bayer’s SeedGrowth Centre will offer stakeholders in the seed treatment business including breeders, seed companies, research facilities , advisors and of course farmers. By taking a holistic view of the seed treatment business, we can offer customers added value that will grow their business,” adds Eckstein.
“Our SeedGrowth Centre brings together significant technological, scientific and manufacturing resources to support sustainable agricultural initiatives and global product stewardship. We are excited to open a facility that not only enhances research and development efforts, but also benefits the entire agriculture community for sustainable future growth," concludes Eckstein.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com or www.bayer.co.za
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.